KCNQ1 and cancer: With a view to exploring possible pharmaceutical approaches that could effectively target LUAD, we utilized the Genomics of Drug Sensitivity in Cancer (GDSC) repository of Q-omics analyses to identify drugs that feature potentiation effects in the context of low KCNQ1 expression.